Prescription for the People : An Activistâ#x80;#x99;s Guide to Making Medicine Affordable for All /

Saved in:
Bibliographic Details
Author / Creator:Quigley, Fran, 1962- author.
Imprint:Ithaca : ILR Press, an imprint of Cornell University Press, 2017. (Baltimore, Md. : Project MUSE, 2015)
Description:1 online resource.
Language:English
Series:The culture and politics of health care work
Book collections on Project MUSE.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11758447
Hidden Bibliographic Details
Other authors / contributors:Project Muse.
ISBN:9781501713910
1501713914
9781501713750 (pbk. : alk. paper)
9781501713927
Notes:Includes bibliographical references and index.
Description based on print version record.
Summary:'A Prescription for Change' diagnoses our medicines problem and prescribes the cure: it delivers a clear and convincing argument for a complete shift in the global and US approach to developing and providing essential medicines - and a primer on how to make that change happen.
Other form:Online version: Quigley, Fran, 1962- author. Prescription for the people Ithaca : ILR Press, an imprint of Cornell University Press, 2017 9781501713927
Table of Contents:
  • People everywhere are struggling to get the medicines they need
  • The United States has a drug problem
  • Millions of people are dying needlessly
  • Cancer patients face particularly deadly barriers to medicines
  • The current medicine system neglects many major diseases
  • Corporate research and development investments are exaggerated
  • The current system wastes billions on drug marketing
  • The current system compromises physician integrity and leads to unethical corporate behavior
  • Medicines are priced at whatever the market will bear
  • Pharmaceutical corporations reap history-making profits
  • The for-profit medicine arguments are patently false
  • Medicine patents are extended too far and too wide
  • Patent protectionism stunts the development of new medicines
  • Governments, not private corporations, drive medicine innovation
  • Taxpayers and patients pay twice for patented medicines
  • Medicines are a public good
  • Medicine patents are artificial, recent, and government-created
  • The United States and big pharma play the bully in extending patents
  • Pharma-pushed trade agreements steal the power of democratically elected governments
  • Current law provides opportunities for affordable generic medicines
  • There is a better way to develop medicines
  • Human rights law demands access to essential medicines.